Vitamin Blue Stock Price Prediction
| VTMB Stock | USD 0.0001 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Vitamin Blue hype-based prediction, you can estimate the value of Vitamin Blue from the perspective of Vitamin Blue response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vitamin Blue to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Vitamin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vitamin Blue after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vitamin |
Vitamin Blue After-Hype Price Prediction Density Analysis
As far as predicting the price of Vitamin Blue at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vitamin Blue or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Vitamin Blue, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vitamin Blue Estimiated After-Hype Price Volatility
In the context of predicting Vitamin Blue's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vitamin Blue's historical news coverage. Vitamin Blue's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Vitamin Blue's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vitamin Blue is very steady at this time. Analysis and calculation of next after-hype price of Vitamin Blue is based on 3 months time horizon.
Vitamin Blue Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vitamin Blue is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vitamin Blue backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vitamin Blue, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 5 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0001 | 0.0001 | 0.00 |
|
Vitamin Blue Hype Timeline
Vitamin Blue is at this time traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vitamin is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Vitamin Blue is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.0. Vitamin Blue had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be any time. Check out Vitamin Blue Basic Forecasting Models to cross-verify your projections.Vitamin Blue Related Hype Analysis
Having access to credible news sources related to Vitamin Blue's direct competition is more important than ever and may enhance your ability to predict Vitamin Blue's future price movements. Getting to know how Vitamin Blue's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vitamin Blue may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PPYAU | Papaya Growth Opportunity | 0.00 | 1 per month | 0.00 | (0.28) | 0.00 | 0.00 | 5.02 | |
| ECVT | Ecovyst | (0.17) | 6 per month | 1.60 | 0.03 | 4.55 | (3.08) | 17.08 | |
| SCL | Stepan Company | (1.40) | 7 per month | 1.55 | (0.06) | 2.04 | (2.72) | 12.17 | |
| ELVA | Electrovaya Common Shares | 0.04 | 3 per month | 2.55 | 0.09 | 6.47 | (3.96) | 20.02 | |
| HDSN | Hudson Technologies | (0.12) | 7 per month | 0.00 | (0.15) | 4.75 | (3.98) | 29.08 | |
| ECL | Ecolab Inc | (2.56) | 11 per month | 0.96 | (0.15) | 1.43 | (1.11) | 4.42 | |
| CDXS | Codexis | 0.22 | 6 per month | 2.53 | 0.16 | 9.28 | (4.64) | 18.89 | |
| HIHO | Highway Holdings Limited | (0.10) | 3 per month | 2.97 | 0.02 | 3.37 | (2.70) | 41.88 |
Vitamin Blue Additional Predictive Modules
Most predictive techniques to examine Vitamin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vitamin using various technical indicators. When you analyze Vitamin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vitamin Blue Predictive Indicators
The successful prediction of Vitamin Blue stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vitamin Blue, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vitamin Blue based on analysis of Vitamin Blue hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vitamin Blue's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vitamin Blue's related companies.
Story Coverage note for Vitamin Blue
The number of cover stories for Vitamin Blue depends on current market conditions and Vitamin Blue's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vitamin Blue is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vitamin Blue's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Vitamin Blue Short Properties
Vitamin Blue's future price predictability will typically decrease when Vitamin Blue's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vitamin Blue often depends not only on the future outlook of the potential Vitamin Blue's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vitamin Blue's indicators that are reflective of the short sentiment are summarized in the table below.
| Short Long Term Debt | 422.7 K |
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Stocks Directory Find actively traded stocks across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |